Biomea Fusion BMEA
NASDAQ BMEA
$1.75 +0.04 (+2.63%)
As of: Sep 22, 2026 · 11:12 AM EDT

Biomea Fusion (BMEA) Non-Current Assets (2020 - 2026)

Biomea Fusion's (BMEA) quarterly Non-Current Assets came in at $445000.0 in Q2 2026, down 94.76% year-over-year from $8.5 million in Q2 2025, and up 564.18% quarter-over-quarter from $67000.0 in Q1 2026.

Analysis

Biomea Fusion (BMEA) Non-Current Assets (2020 - 2026) Analysis & Trends

Biomea Fusion has disclosed Non-Current Assets across 7 years of filings, most recently posting $445000.0 for Q2 2026.

  • In Q2 2026, Non-Current Assets fell 94.76% year-over-year to $445000.0; the TTM figure through Jun 2026 stood at $6.8 million (down 85.66% YoY), while the FY2025 annual figure was $522000.0, down 95.5% from the prior year.
  • Non-Current Assets came in at $445000.0 for Q2 2026 at Biomea Fusion, up from $67000.0 in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $23.7 million in Q1 2023 to a low of $67000.0 in Q1 2026.
  • Average Non-Current Assets over 5 years is $12.1 million, with a median of $10.9 million recorded in 2022.
  • Year-over-year, Non-Current Assets jumped 264.89% in 2023 and plunged 99.35% in 2026.
  • Over 5 years, Non-Current Assets stood at $11.5 million in 2022, then surged by 80.59% to $20.7 million in 2023, then slumped by 44.06% to $11.6 million in 2024, then tumbled by 95.5% to $522000.0 in 2025, then fell by 14.75% to $445000.0 in 2026.
  • Per Business Quant data, the three most recent Non-Current Assets figures were $445000.0 in Q2 2026, $67000.0 in Q1 2026, and $522000.0 in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Johnson & Johnson 650.65 Bn 629.89 Bn 17.26 Bn 141.29 Bn
2 AbbVie 466.34 Bn 459.82 Bn 12.70 Bn 101.45 Bn
3 Merck 362.11 Bn 355.02 Bn 12.21 Bn 125.00 Mn
4 Novartis Ag 267.81 Bn 260.52 Bn 11.24 Bn 94.68 Bn
5 Pfizer 157.31 Bn 145.91 Bn 10.94 Bn 159.77 Bn
6 Bristol Myers Squibb 128.75 Bn 117.69 Bn 9.25 Bn 59.06 Bn
7 Sanofi 51.80 Bn 44.84 Bn 10.79 Bn 113.37 Bn
8 Revolution Medicines 40.91 Bn 40.91 Bn - 294.93 Mn
9 BeOne Medicines 39.65 Bn 34.55 Bn 1.53 Bn 1.96 Bn
10 Biomea Fusion 132.65 Mn 132.65 Mn - 445,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 445,000.00
Mar 31, 2026 67,000.00
Dec 31, 2025 522,000.00
Sep 30, 2025 5.75 Mn
Jun 30, 2025 8.50 Mn
Mar 31, 2025 10.37 Mn
Dec 31, 2024 11.61 Mn
Sep 30, 2024 16.82 Mn
Jun 30, 2024 19.88 Mn
Mar 31, 2024 20.93 Mn
Dec 31, 2023 20.75 Mn
Sep 30, 2023 22.58 Mn
Jun 30, 2023 22.74 Mn
Mar 31, 2023 23.71 Mn
Dec 31, 2022 11.49 Mn
Sep 30, 2022 6.19 Mn
Jun 30, 2022 7.60 Mn
Mar 31, 2022 7.84 Mn
Dec 31, 2021 9.14 Mn
Sep 30, 2021 8.30 Mn
API Access

Biomea Fusion Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-assets&ticker=BMEA&period=max&api_key=YOUR_API_KEY